Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report

Abatacept as salvage therapy for life-threatening refractory autoimmune hemolytic anemia: a case report

Autoimmune hemolytic anemia (AIHA) can be life-threatening, if hemoglobin (Hb) levels continue to decline after established treatments with glucocorticoids, rituximab, intravenous immunoglobulins, and plasmapheresis. Impaired regulatory T cells (Treg) are proposed to alleviate AIHA development th...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Hoffmann, Joerg, Schliesser, Georg, Neubauer, Andreas
Aineistotyyppi: Artikkeli
Kieli:englanti
Julkaistu: Philipps-Universität Marburg 2023
Aiheet:
autoimmune hemolytic anemia; hemolysis
Abatacept
case report
CTLA-4
Medizin
Medical sciences Medicine
Linkit:PDF-kokoteksti
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
No citations were found for this record.

Samankaltaisia teoksia